DRREDDY vs HINDALCO: Stock Comparison
HINDALCO INDUSTRIES is the larger company by market capitalisation. DR. REDDY S LABORATORIES shows a higher dividend yield, lower leverage and a higher ROCE, while HINDALCO INDUSTRIES shows a lower P/E, a higher ROE and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
DRREDDY leads 5; HINDALCO leads 8 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | DRREDDY | HINDALCO |
|---|---|---|
| Sector | Healthcare | Metals & Mining |
| Industry | Pharmaceuticals | Aluminium |
Price
| Metric | DRREDDY | HINDALCO |
|---|---|---|
| Live Price | ₹1,197 | ₹900.35 |
| Day Change | 1.44% | 1.15% |
| Volume | 15.1 L | 34.99 L |
| 52-Week High | ₹1,414.9 | ₹1,176 |
| 52-Week Low | ₹1,101 | ₹754.45 |
| Distance from 52W High | -15.4% | -23.44% |
Valuation
| Metric | DRREDDY | HINDALCO |
|---|---|---|
| Market Cap | ₹99,752 Cr | ₹2.02 L Cr |
| P/E Ratio | 30.95x | 12.32x |
| P/B Ratio | 2.63x | 1.48x |
| EPS | ₹5.32 | ₹31.21 |
| Book Value | ₹458.03 | ₹607.84 |
| Dividend Yield | 0.67% | 0.56% |
Growth
| Metric | DRREDDY | HINDALCO |
|---|---|---|
| Revenue Growth (TTM YoY) | -11.6% | 20.4% |
| EPS Growth (TTM YoY) | -86.2% | -50.9% |
| Qtr Sales Growth | 57.69% | 177.98% |
| Qtr Profit Growth | 7.64% | 46.59% |
Profitability & Leverage
| Metric | DRREDDY | HINDALCO |
|---|---|---|
| ROE | 10.87% | 13.14% |
| ROCE | 13.38% | 11.64% |
| Net Margin | 12.76% | 4.87% |
| Operating Margin | 17.07% | 13.43% |
| Debt to Equity | 0.16x | 0.22x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | DRREDDY | HINDALCO |
|---|---|---|
| Promoter Holding | 26.64%▲ 0.01 pp | 34.01%▲ 0.02 pp |
| FII Holding | 32.07%▼ 1.01 pp | 35.6%▲ 1.47 pp |
| DII Holding | 31.74%▲ 1.02 pp | 19.95%▼ 1.52 pp |
| Public Holding | 9.35%▲ 0.02 pp | 9.1%▲ 0.07 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: DR. REDDY S LABORATORIES and HINDALCO INDUSTRIES .
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.